The vir gene of bacteriophage MAV1 confers resistance to phage infection on Mycoplasma arthritidis

Journal of Bacteriology

Volumn 186, Issue 17, 2004, Pages 5715-5720

  Clapper, Brenda ^a   Tu, Anh Hue T ^b   Elgavish, Ada ^b   Dybvig, Kevin ^a,b  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIOPHAGE DNA; LIPOPROTEIN; PROTEIN VIR; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIOPHAGE; BACTERIOPHAGE MAV1; CONTROLLED STUDY; CYTOPLASM; GENE INSERTION; GENETIC TRANSCRIPTION; MYCOPLASMA ARTHRITIDIS; NONHUMAN; PRIORITY JOURNAL; VIRUS GENE;

ANIMALS; BACTERIAL PROTEINS; BIOLOGICAL TRANSPORT; CAUDOVIRALES; DISEASE MODELS, ANIMAL; DNA, VIRAL; LIPOPROTEINS; LYSOGENY; MEMBRANE PROTEINS; MYCOPLASMA ARTHRITIDIS; MYCOPLASMA INFECTIONS; RATS; VIRAL INTERFERENCE; VIRAL PROTEINS; VIRULENCE; VIRULENCE FACTORS; VIRUS REPLICATION;

ACTINOBACTERIA (CLASS); BACTERIA (MICROORGANISMS); INSERTION SEQUENCES; MYCOPLASMA; MYCOPLASMA ARTHRITIDIS; MYCOPLASMATALES; TRANSPOSONS; UNCULTURED ACTINOMYCETE; VIR;

EID: 4344623306     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/JB.186.17.5715-5720.2004     Document Type: Article

References (24)

1. Allison, G. E., and T. R. Klaenhammer. 1998. Phage resistance mechanisms in lactic acid bacteria. Int. Dairy J. 8:207-226.
2. Bordier, C. 1981. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256:1604-1607.
3. Butler, S. H., J. Weil-Fugazza, F. Godefroy, and J. M. Besson. 1985. Reduction of arthritis and pain behaviour following chronic administration of amitriptyline or imipramine in rats with adjuvant-induced arthritis. Pain 23:159-175.
4. Cole, B. C. 1991. The immunobiology of Mycoplasma arthritidis and its superantigen MAM. Curr. Top. Microbiol. Immunol. 174:107-119.
5. Cole, B. C., and C. L. Atkin. 1991. The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. Immunol. Today 12:271-276.
6. Dahl, J. 1993. The role of cholesterol in mycoplasma membranes. Subcell. Biochem. 20:167-188.
7. Duffy, D. F., A. H. Noormohammadi, N. Basseggio, G. F. Browning, and P. F. Markham. 1998. Immunological and biochemical characterization of membrane proteins, p. 279-298. In R. Nicholas (ed.), Methods in molecular biology, vol. 104. Humana Press, Inc., Totowa, N.J.
8. Dybvig, K., C. T. French, and L. L. Voelker. 2000. Construction and use of derivatives of transposon Tn4001 that function in Mycoplasma pulmonis and Mycoplasma arthritidis. J. Bacteriol. 182:4343-4347.
9. Dybvig, K., and L. L. Voelker. 1996. Molecular biology of mycoplasmas. Annu. Rev. Microbiol. 50:25-57.
10. Fraser, C. F., J. D. Gocayne, O. White, M. D. Adams, R. A. Clayton, R. D. Fleischmann, C. J. Bult, A. R. Kerlavage, G. Sutton, J. M. Kelley, J. L. Fritchman, J. F. Weidman, K. V. Small, M. Sandusky, J. Fuhrmann, D. Nguyen, T. R. Utterback, D. M. Saudek, C. A. Phillips, J. M. Merrick, J.-F. Tomb, B. A. Dougherty, K. F. Bott, P.-C. Hu, T. S. Lucier, S. N. Peterson, H. O. Smith, C. A. Hutchison III, and J. C. Venter. 1995. The minimal gene complement of Mycoplasma genitalium. Science 270:397-403.
11. Hofer, B., M. Ruge, and B. Dreiseikelmann. 1995. The superinfection exclusion gene (sieA) of bacteriophage P22: identification and overexpression of the gene and localization of the gene product. J. Bacteriol. 177:3080-3086.
12. Lu, M. J., Y. D. Stierhof, and U. Henning. 1993. Location and unusual membrane topology of the immunity protein of the Escherichia coli phage T4. J. Virol. 67:4905-4913.
13. Maillou, J., and B. Dreiseikelmann. 1990. The sim gene of Escherichia coli phage P1: nucleotide sequence and purification of the processed protein. Virology 175:500-507.
14. McGrath, S., G. F. Fitzgerald, and D. van Sinderen. 2002. Identification and characterization of phage-resistance genes in temperate lactococcal bacteriophages. Mol. Microbiol. 43:509-520.
15. Nesper, J., J. Blass, M. Fountoulakis, and J. Reidl. 1999. Characterization of the major control region of Vibrio cholerae bacteriophage K139: immunity, exclusion, and integration. J. Bacteriol. 181:2902-2913.
16. Roske, K., M. J. Calcutt, and K. S. Wise. 2004. The Mycoplasma fermentans prophage φMFV1: genome organization, mobility and variable expression of an encoded surface protein. Mol. Microbiol. 52:1703-1720.
17. Teachman, A. M., C. T. French, H. Yu, W. L. Simmons, and K. Dybvig. 2002. Gene transfer in Mycoplasma pulmonis. J. Bacteriol. 184:947-951.
18. Voelker, L. L., and K. Dybvig. 1998. Characterization of the lysogenic bacteriophage MAV1 from Mycoplasma arthritidis. J. Bacteriol. 180:5928-5931.
19. Voelker, L. L., and K. Dybvig. 1998, Demonstration of extrachromosomal elements. Methods Mol. Biol. 104:239-246.
20. Voelker, L. L., and K. Dybvig. 1996. Gene transfer in Mycoplasma arthritidis: transformation, conjugal transfer of Tn916, and evidence for a restriction system recognizing AGCT. J. Bacteriol. 178:6078-6081.
21. Voelker, L. L., and K. Dybvig. 1999, Sequence analysis of the Mycoplasma arthritidis bacteriophage MAV1 genome identifies the putative virulence factor. Gene 233:101-107.
22. Voelker, L. L., K. E. Weaver, L. J. Ehle, and L. R. Washburn. 1995. Association of lysogenic bacteriophage MAV1 with virulence of Mycoplasma arthritidis. Infect. Immun. 63:4016-4023.
23. Vostrov, A. A., O. A. Vostrukhina, A. N. Svarchevsky, and V. N. Rybchin. 1996. Proteins responsible for lysogenic conversion caused by coliphages N15 and phi80 are highly homologous. J. Bacteriol. 178:1484-1486.
24. Washburn, L. R., and E. J. Weaver. 1997. Protection of rats against Mycoplasma arthritidis-induced arthritis by active and passive immunizations with two surface antigens. Clin. Diagn. Lab. Immunol. 4:321-327.